Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME)
Anne Catherine Bretz, Ulrike Parnitzke, Kerstin Kronthaler, Tobias Dreker, René Bartz, Frank Hermann, Astrid Ammendola, Tanja Wulff, Svetlana Hamm
Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 294; DOI: 10.1186/s40425-019-0745-3